Double-Blind, Randomized, Placebo-Controlled Study of Immediate-Release Viloxazine (SPN-812IR) as a Novel Non-Stimulant Therapy in Adults With ADHD

New Research Poster Presentation 2.28
Double-Blind, Randomized, Placebo-Controlled Study of Immediate-Release Viloxazine (SPN-812IR) as a Novel Non-Stimulant Therapy in Adults With ADHD

Thursday, October 29, 2015 10:00 AM

Janet A. Johnson, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD

Keith Saylor, PhD, NeuroScience Inc., Herndon, VA

Scott T. Brittain, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD

Gabriela Tulloch, Supernus Pharmaceuticals, Inc., Rockville, MD

Tesfaye Liranso, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD